TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued.

Take a closer look at TG THERAPEUTICS INC (NASDAQ:TGTX), an affordable growth stock uncovered by our stock screener. NASDAQ:TGTX boasts strong growth prospects and excels in financial health indicators, all while maintaining a reasonable valuation. Let's break it down further.

Understanding NASDAQ:TGTX's Growth

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:TGTX boasts a 8 out of 10:

• The Earnings Per Share has grown by an impressive 1300.00% over the past year.
• The Revenue has grown by 40.80% in the past year. This is a very strong growth!
• The Revenue has been growing by 365.82% on average over the past years. This is a very strong growth!
• Based on estimates for the next years, TGTX will show a very strong growth in Earnings Per Share. The EPS will grow by 97.84% on average per year.
• The Revenue is expected to grow by 38.09% on average over the next years. This is a very strong growth

Looking at the Valuation

ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NASDAQ:TGTX was assigned a score of 5 for valuation:

• Based on the Price/Earnings ratio, TGTX is valued cheaply inside the industry as 91.96% of the companies are valued more expensively.
• 92.31% of the companies in the same industry are more expensive than TGTX, based on the Price/Forward Earnings ratio.
• Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TGTX indicates a rather cheap valuation: TGTX is cheaper than 92.48% of the companies listed in the same industry.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• The decent profitability rating of TGTX may justify a higher PE ratio.
• A more expensive valuation may be justified as TGTX's earnings are expected to grow with 166.06% in the coming years.

How do we evaluate the Health for NASDAQ:TGTX?

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:TGTX scores a 5 out of 10:

• TGTX has an Altman-Z score of 8.29. This indicates that TGTX is financially healthy and has little risk of bankruptcy at the moment.
• TGTX's Altman-Z score of 8.29 is amongst the best of the industry. TGTX outperforms 86.19% of its industry peers.
• TGTX has a Current Ratio of 6.25. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.
• TGTX's Current ratio of 6.25 is fine compared to the rest of the industry. TGTX outperforms 64.69% of its industry peers.
• TGTX has a Quick Ratio of 5.03. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.

A Closer Look at Profitability for NASDAQ:TGTX

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:TGTX, the assigned 6 is noteworthy for profitability:

• With an excellent Return On Assets value of 4.05%, TGTX belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
• Looking at the Return On Equity, with a value of 10.52%, TGTX belongs to the top of the industry, outperforming 95.10% of the companies in the same industry.
• TGTX's Return On Invested Capital of 6.80% is amongst the best of the industry. TGTX outperforms 94.58% of its industry peers.
• TGTX's Profit Margin of 7.11% is amongst the best of the industry. TGTX outperforms 93.53% of its industry peers.
• The Operating Margin of TGTX (12.74%) is better than 95.10% of its industry peers.
• The Gross Margin of TGTX (88.30%) is better than 90.73% of its industry peers.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Check the latest full fundamental report of TGTX for a complete fundamental analysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.